Bola Adel Alfy Hakim*

Department of Orthopedic Surgery, General Authority of Healthcare, Luxor Branch, Egypt

*Corresponding Author: Bola Adel Alfy Hakim, Department of Orthopedic Surgery, General Authority of Healthcare, Luxor Branch, Egypt.

Received: August 24, 2021; Published: September 01, 2021

  Benign bone tumors often weaken bone and make patients vulnerable to pathological fractures [1]. Benign lytic bone lesions such as Simple Bone Cyst (SBC), Non-Ossifying Fibroma (NOF) and Fibrous Dysplasia (FD), etc. commonly affect the young people. These lesions, which are usually asymptomatic, are stabilized or usually disappear after skeletal maturaty. Therefore, surgical operation is generally now not required until the size of the lesion is prone to pathological fractures, in which case curettage and grafting are the widespread treatment [2].

References

1. Wu PK., et al. “Grafting for bone defects after curettage of benign bone tumor – Analysis of factors influencing the bone healing”. Journal of the Chinese Medical Association7 (2018): 643-648.
2. Moretti VM., et al. “Curettage and graft alleviates athletic-limiting pain in benign lytic bone lesions”. Clinical Orthopaedics and Related Research1 (2011): 283-288.
3. Ramirez JM., et al. “Benign Bone Tumors”. In: Essential Orthopedic Review: Questions and Answers for Senior Medical Students (2018): 357-358.
4. Woertler K. “Benign bone tumors and tumor-like lesions: Value of cross-sectional imaging”. European Radiology8 (2003): 1820-1835.
5. Donaldson SE., et al. “Treatment for unicameral bone cysts in long bones: an evidence based review”. Orthopedic Reviews1 (2010): 13.
6. Hirn M., et al. “Bone defects following curettage do not necessarily need augmentation: A retrospective study of 146 patients”. Acta Orthopaedica1 (2009): 4-8.
7. Horstmann PF., et al. “Treatment of benign and borderline bone tumors with combined curettage and bone defect reconstruction”. Journal of Orthopaedic Surgery3 (2018): 1-7.
8. Nandi SK., et al. “Orthopaedic applications of bone graft and graft substitutes: A review”. Indian Journal of Medical Research7 (2010): 15-30.
9. Roberts TT and Rosenbaum AJ. “Bone grafts, bone substitutes and orthobiologics”. Organogenesis4 (2012): 114-124.
10. Zhao JG., et al. “Interventions for treating simple bone cysts in the long bones of children”. The Cochrane Database of Systematic Reviews 11 (2013).
11. Saikia KC., et al. “Calcium phosphate ceramics as bone graft substitutes in filling bone tumor defects”. The Indian Journal of Orthopaedics2 (2008): 169-172.
12. Fernandez de Grado G., et al. “Bone substitutes: a review of their characteristics, clinical use, and perspectives for large bone defects management”. Journal of Tissue Engineering - SAGE Journals (2018): 9.
13. Senra MR and Marques M de FV. “Synthetic Polymeric Materials for Bone Replacement”. Journal of Composites Science4 (2020): 191.
14. Gupta SP and Garg G. “Curettage with cement augmentation of large bone defects in giant cell tumors with pathological fractures in lower-extremity long bones”. Journal of Orthopaedics and Traumatology3 (2016): 239-247.
15. Chen CJ and Brien EW. “Early postoperative compilations of bone filling in curettage defects”. Journal of Orthopaedic Surgery and Research1 (2019): 1-12.
16. Zheng K., et al. “How to fill the cavity after curettage of giant cell tumors around the knee? A multicenter analysis”. Chinese Medical Journal21 (2017): 2541-2546.

Citation

Citation: Bola Adel Alfy Hakim. “Benign Bone Tumors, An Overview".Acta Scientific Orthopaedics 4.10 (2021): 01-02.

Copyright

Copyright: © 2021 Bola Adel Alfy Hakim. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.